The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Congress 2022 | JAK2V617F VAF: clinical significance and applications in polycythemia vera
Alison Moliterno
• 24 Nov 2022
Alison Moliterno, MD, Johns Hopkins University School of Medicine, Baltimore, MD, gives a presentation on the clinical significance and applications of JAK2V617F variant allele fraction (VAF) in polycythemia vera (PV) at the 14th International Congress on Myeloproliferative Neoplasms (MPNs) held in New York City, NY.
